期刊
NATURE CANCER
卷 1, 期 8, 页码 784-+出版社
NATURE PORTFOLIO
DOI: 10.1038/s43018-020-0104-9
关键词
-
类别
资金
- Italian Association for Cancer Research [AIRC 6421]
- Italian Health Ministry's research program 'Performance evaluation and value assessment for cardiovascular and oncological care path in a regional network context: challenges and opportunities' [NET-2016-02363853]
In 84,246 consecutive Italians tested for SARS-CoV-2, we examined the prevalence of cancer and clinical outcomes of viral infection. Overall, 5.7% (4,789/84,246) had previously been diagnosed with cancer and, among the SARS-CoV-2-positive (CV2+ve) patients, 7.8% had a cancer diagnosis (723/9,275). Prevalence of cancer was not associated with risk of infection (odds ratio of 0.97; 95% confidence interval of 0.89-1.06). The proportion of CV2+ve people hospitalized was higher among patients with cancer (56.6 versus 34.4% among other people), and so was the proportion of deaths (14.7% versus 4.5%). The risk of adverse outcomes of SARS-CoV-2 infection was significantly higher for patients with cancer versus those without, particularly for males and older people. Rugge and colleagues report that patients with cancer, particularly those who are older and male, face a significantly increased risk of adverse outcomes of SARS-CoV-2 infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据